Paper17200713
Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing.
Mahley RW and 1 other. J Clin Invest, 2007. Cited by 131 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing. Papers, record 17200713. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17200713
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Atherosclerosis | Major topic |
| Heparan Sulfate Proteoglycans | Major topic |
| Lipoproteins | Major topic |
| Liver | Major topic |
| Proteoglycans | Major topic |
| Biological Transport | |
| Humans | |
| Models, Biological | |
| Receptors, LDL | |
| Triglycerides |
Source PubMed
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment on | 17200715 | Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. | https://conductscience.org/library/papers/17200715 | PubMed |
| Comment on | 17200716 | Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia. | https://conductscience.org/library/papers/17200716 | PubMed |
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8175773 | Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia. | J Biol Chem | 1994 | https://conductscience.org/library/papers/8175773 | PubMed |
| 2 | 11326085 | Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. | Science | 2001 | https://conductscience.org/library/papers/11326085 | PubMed |
| 3 | 7773575 | Lipoprotein and receptor interactions in vivo. | Curr Opin Lipidol | 1995 | https://conductscience.org/library/papers/7773575 | PubMed |
| 4 | 7539827 | Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans. | J Lipid Res | 1995 | https://conductscience.org/library/papers/7539827 | PubMed |
| 5 | 8798405 | Role of the low density lipoprotein (LDL) receptor pathway in the metabolism of chylomicron remnants. A quantitative study in knockout mice lacking the LDL receptor, apolipoprotein E, or both. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8798405 | PubMed |
| 6 | 9294130 | The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro. | J Clin Invest | 1997 | https://conductscience.org/library/papers/9294130 | PubMed |
| 7 | 9335948 | Cell-surface heparan sulfate proteoglycans: dynamic molecules mediating ligand catabolism. | Curr Opin Lipidol | 1997 | https://conductscience.org/library/papers/9335948 | PubMed |
| 8 | 9395455 | Heparan sulfate proteoglycans participate in hepatic lipaseand apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins. | J Biol Chem | 1997 | https://conductscience.org/library/papers/9395455 | PubMed |
| 9 | 9409260 | Genetic factors precipitating type III hyperlipoproteinemia in hypolipidemic transgenic mice expressing human apolipoprotein E2. | Arterioscler Thromb Vasc Biol | 1997 | https://conductscience.org/library/papers/9409260 | PubMed |
| 10 | 9449704 | Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. | J Clin Invest | 1998 | https://conductscience.org/library/papers/9449704 | PubMed |
| 11 | 9555948 | Chylomicron remnant uptake is regulated by the expression and function of heparan sulfate proteoglycan in hepatocytes. | J Lipid Res | 1998 | https://conductscience.org/library/papers/9555948 | PubMed |
| 12 | 9593771 | Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma. | J Clin Invest | 1998 | https://conductscience.org/library/papers/9593771 | PubMed |
| 13 | 9869645 | Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. | J Lipid Res | 1999 | https://conductscience.org/library/papers/9869645 | PubMed |
| 14 | 16410459 | Lipoprotein lipase bound to apolipoprotein B lipoproteins accelerates clearance of postprandial lipoproteins in humans. | Arterioscler Thromb Vasc Biol | 2006 | https://conductscience.org/library/papers/16410459 | PubMed |
| 15 | 17200715 | Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17200715 | PubMed |
| 16 | 17200716 | Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17200716 | PubMed |
| 17 | 8182153 | Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice. | J Clin Invest | 1994 | https://conductscience.org/library/papers/8182153 | PubMed |
| 18 | 10872465 | Functions of cell surface heparan sulfate proteoglycans. | Annu Rev Biochem | 1999 | https://conductscience.org/library/papers/10872465 | PubMed |
| 19 | 10591675 | Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidemia by stimulating hepatic VLDL production and impairing VLDL lipolysis. | Arterioscler Thromb Vasc Biol | 1999 | https://conductscience.org/library/papers/10591675 | PubMed |
| 20 | 12045103 | Order out of chaos: assembly of ligand binding sites in heparan sulfate. | Annu Rev Biochem | 2002 | https://conductscience.org/library/papers/12045103 | PubMed |
Cited by82
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 131 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42260855 | Discordance between remnant cholesterol and LDL-C associated with the risk of new-onset cardiometabolic multimorbidity: A prospective cohort study. | Medicine (Baltimore) | 2026 | https://conductscience.org/library/papers/42260855 | PubMed |
| 42074213 | Current and Emerging Pharmacological Therapies for Hypertriglyceridemia. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074213 | PubMed |
| 41516253 | Rodent Models for Atherosclerosis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516253 | PubMed |
| 41400334 | Heparin-Binding Proteins in the Nanoparticle Corona Enhance Cellular Uptake through Glycocalyx Interactions. | ACS Nano | 2025 | https://conductscience.org/library/papers/41400334 | PubMed |
| 39743565 | Apolipoprotein B-containing lipoproteins in atherogenesis. | Nat Rev Cardiol | 2025 | https://conductscience.org/library/papers/39743565 | PubMed |
| 39031302 | Recent Advances in Targeted Management of Inflammation In Atherosclerosis: A Narrative Review. | Cardiol Ther | 2024 | https://conductscience.org/library/papers/39031302 | PubMed |
| 38540127 | Protective Effects of High-Density Lipoprotein on Cancer Risk: Focus on Multiple Myeloma. | Biomedicines | 2024 | https://conductscience.org/library/papers/38540127 | PubMed |
| 38039351 | Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance. | Cardiovasc Res | 2024 | https://conductscience.org/library/papers/38039351 | PubMed |
| 37842298 | Remnant cholesterol associates with hypertension beyond low-density lipoprotein cholesterol among the general US adult population. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37842298 | PubMed |
| 37055761 | A review of the regulatory mechanisms of extracellular vesicles-mediated intercellular communication. | Cell Commun Signal | 2023 | https://conductscience.org/library/papers/37055761 | PubMed |
| 36073641 | ANGPTL3 and Cardiovascular Outcomes in Patients With Acute Coronary Syndrome and Obstructive Sleep Apnea. | J Am Heart Assoc | 2022 | https://conductscience.org/library/papers/36073641 | PubMed |
| 35653195 | Interventional hepatic apoC-III knockdown improves atherosclerotic plaque stability and remodeling by triglyceride lowering. | JCI Insight | 2022 | https://conductscience.org/library/papers/35653195 | PubMed |
| 35135057 | Hypertriglyceridemia: A Neglected Risk Factor for Ischemic Stroke? | J Stroke | 2022 | https://conductscience.org/library/papers/35135057 | PubMed |
| 35087857 | Mechanisms for Improving Hepatic Glucolipid Metabolism by Cinnamic Acid and Cinnamic Aldehyde: An Insight Provided by Multi-Omics. | Front Nutr | 2021 | https://conductscience.org/library/papers/35087857 | PubMed |
| 34676434 | Metabolism of Triglyceride-Rich Lipoproteins. | Handb Exp Pharmacol | 2022 | https://conductscience.org/library/papers/34676434 | PubMed |
| 34625741 | Apolipoproteins in vascular biology and atherosclerotic disease. | Nat Rev Cardiol | 2022 | https://conductscience.org/library/papers/34625741 | PubMed |
| 34472586 | Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. | Eur Heart J | 2021 | https://conductscience.org/library/papers/34472586 | PubMed |
| 34068576 | Differences in Recycling of Apolipoprotein E3 and E4-LDL Receptor Complexes-A Mechanistic Hypothesis. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34068576 | PubMed |
| 34067469 | Triglyceride-Rich Lipoproteins and Their Remnants as Silent Promoters of Atherosclerotic Cardiovascular Disease and Other Metabolic Disorders: A Review. | Nutrients | 2021 | https://conductscience.org/library/papers/34067469 | PubMed |
| 33842343 | The Lipoprotein Transport System in the Pathogenesis of Multiple Myeloma: Advances and Challenges. | Front Oncol | 2021 | https://conductscience.org/library/papers/33842343 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17200713
GET https://conductscience.org/api/papers/v1/17200713/references?page=2